LivaNova PLC (NASDAQ:LIVN) Issues FY17 Earnings Guidance
LivaNova PLC (NASDAQ:LIVN) issued an update on its FY17 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.10-3.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.10.
Shares of LivaNova PLC (NASDAQ:LIVN) opened at 61.31 on Wednesday. The firm’s 50-day moving average price is $61.60 and its 200 day moving average price is $54.55. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $63.21. The firm’s market cap is $2.99 billion.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.19. LivaNova PLC had a positive return on equity of 8.77% and a negative net margin of 0.92%. The firm had revenue of $321.40 million during the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC’s quarterly revenue was up .1% on a year-over-year basis. On average, equities research analysts forecast that LivaNova PLC will post $3.11 EPS for the current fiscal year.
Separately, BidaskClub downgraded LivaNova PLC from a strong-buy rating to a buy rating in a report on Monday, July 24th.
In related news, Director Alfred J. Novak sold 1,000 shares of the stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $58.49, for a total value of $58,490.00. Following the completion of the sale, the director now directly owns 12,020 shares in the company, valued at approximately $703,049.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders sold 3,000 shares of company stock valued at $180,840. 0.28% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “LivaNova PLC (NASDAQ:LIVN) Issues FY17 Earnings Guidance” was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/09/livanova-plc-nasdaqlivn-issues-fy17-earnings-guidance.html.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.